|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Blackwell, K.; Gascon, P.; Krendyukov, A.; Gattu, S.; Li, Y. und Harbeck, N.
(2018):
Safety and efficacy of alternating treatment with EP2006, a filgrastim biosimilar, and reference filgrastim: a phase III, randomised, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy.
In: Annals of Oncology, Bd. 29, Nr. 1: S. 244-249
Blackwell, K.; Gascon, P.; Jones, C. M.; Nixon, A.; Krendyukov, A.; Nakov, R.; Li, Y. und Harbeck, N.
(2017):
Pooled analysis of two randomized, double-blind trials comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer.
In: Annals of Oncology, Bd. 28, Nr. 9: S. 2272-2277
Harbeck, N.; Zbarskaya, I.; Lipatov, O.; Frolova, M.; Udovitsa, D.; Topuzov, E.; Ganea-Motan, D. E.; Nakov, R.; Singh, P.; Rudy, A. und Blackwell, K.
(2016):
A randomized, double-blind trial to compare the efficacy and safety of proposed biosimilar pegfilgrastim (LA-EP2006) with reference pegfilgrastim in patients with breast cancer (PROTECT1).
In: Cancer Research, Bd. 76